Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Dana-Farber Cancer Institute
Eli Lilly and Company
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
GlaxoSmithKline
Mayo Clinic